Aspergillus bronchitis in cystic fibrosis

被引:132
作者
Shoseyov, David
Brownlee, Keith G.
Conway, Steven P.
Kerem, Eitan
机构
[1] Hadassah Univ Hosp, Dept Pediat, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, CF Ctr, IL-91120 Jerusalem, Israel
[3] St James Univ Hosp, Paediat Ctr, Leeds LS9 7TF, W Yorkshire, England
[4] St James Univ Hosp, Adult Reg Cyst Fibrosis Ctr, Leeds LS9 7TF, W Yorkshire, England
[5] Seacroft Univ Hosp, Paediat Ctr, Leeds, W Yorkshire, England
[6] Seacroft Univ Hosp, Adult Reg Cyst Fibrosis Ctr, Leeds, W Yorkshire, England
关键词
allergic bronchopulmonary aspergillosis; antifungal therapy; Aspergillus fumigatus; cystic fibrosis;
D O I
10.1378/chest.130.1.222
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aspergillus fumigatus, a widely distributed spore-bearing fungus, is commonly grown in sputum cultures of patients with cystic fibrosis (CF). A fumigatus may cause allergic bronchopulmonary aspergillosis (ABPA), a complex condition that leads to worsening of airway inflammation and progressive damage and is diagnosed by specific criteria. In this report, we present six CF patients with respiratory deterioration that did not respond to appropriate antibiotic treatment. All had had A fumigatus in sputum cultures but did not fulfill the criteria of ABPA. Treatment with antifungal agents was followed by improvement in clinical condition. We suggest that in patients with CF, A fumigatus should be considered as a pathogen that may directly cause respiratory exacerbations. Antifungal therapy should be considered when deteriorating respiratory function is not responding to antibacterial therapy and A fumigatus is growing in sputum cultures.
引用
收藏
页码:222 / 226
页数:5
相关论文
共 17 条
[1]   Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus [J].
Banerjee, B ;
Kurup, VP ;
Greenberger, PA ;
Hoffman, DR ;
Nair, DS ;
Fink, JN .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (06) :821-827
[2]   CYSTIC-FIBROSIS - SCORING SYSTEM WITH THIN-SECTION CT [J].
BHALLA, M ;
TURCIOS, N ;
APONTE, V ;
JENKINS, M ;
LEITMAN, BS ;
MCCAULEY, DI ;
NAIDICH, DP .
RADIOLOGY, 1991, 179 (03) :783-788
[3]   EVALUATION OF SCORING SYSTEM OF THE CHEST RADIOGRAPH IN CYSTIC-FIBROSIS - A COLLABORATIVE STUDY [J].
BRASFIELD, D ;
HICKS, G ;
SOONG, S ;
PETERS, J ;
TILLER, R .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1980, 134 (06) :1195-1198
[4]  
Caputo R, 2003, Expert Rev Anti Infect Ther, V1, P531, DOI 10.1586/14787210.1.4.531
[5]   Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis [J].
Conway, SP ;
Etherington, C ;
Peckham, DG ;
Brownlee, KG ;
Whitehead, A ;
Cunliffe, H .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) :841-847
[6]   PULMONARY ASPERGILLOSIS IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
DENNING, DW ;
FOLLANSBEE, SE ;
SCOLARO, M ;
NORRIS, S ;
EDELSTEIN, H ;
STEVENS, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (10) :654-662
[7]   Allergic bronchopulmonary aspergillosis in cystic fibrosis - Reported prevalence, regional distribution, and patient characteristics [J].
Geller, DE ;
Kaplowitz, H ;
Light, MJ ;
Colin, AA .
CHEST, 1999, 116 (03) :639-646
[8]  
GREENBERGER PA, 1986, ANN ALLERGY, V56, P444
[9]   Management of systemic fungal infections:: alternatives to itraconazole [J].
Herbrecht, R ;
Nivoix, Y ;
Fohrer, C ;
Natarajan-Amé, S ;
Letscher-Bru, V .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 :39-48
[10]   A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis [J].
Hutcheson, PS ;
Knutsen, AP ;
Rejent, AJ ;
Slavin, RG .
CHEST, 1996, 110 (02) :363-366